MedWorm Tags: activation

Priority 1 Trauma Activation

Inside Surgery — Tue, 11 Jan 2011 05:50:22 +0100

Although trauma protocols differ slightly from center to center, most major trauma centers use criteria similar to the following to activate a level 1 (i.e., highest) response: 1. Blood pressure < 90 mmHg in adults and age specific hypotension in children 2. Intubated patients or presence of respiratory compromise 3. Ongoing blood transfusion or intravenous fluid administration to maintain vital signs 4. Penetrating trauma to the neck, chest, abdomen, flanks, proximal leg above the knee, proximal arm above the elbow 5. Glasgow coma scale 8 or less 6. Trauma or emergency room physician discretion (Source: Inside Surgery)

Directed Aromatic C-H Nitration

Organometallic Current — Thu, 11 Nov 2010 08:14:00 +0100

CHEMEURJRegiospecific Synthesis of Nitroarenes by Palladium-Catalyzed Nitrogen-Donor-Directed Aromatic C-H NitrationYun-Kui Liu, Shao-Jie Lou, Dan-Qian Xu and Zhen-Yuan Xu (Source: Organometallic Current)

Just doing it: Behavioural Activation

HealthSkills Weblog — Mon, 12 Apr 2010 19:31:38 +0100

This post is sparked by a pre-print paper I read yesterday, but follows a long time cogitating about the use and value of “just doing it”. Behavioural reactivation is a set of techniques often used for mood management. It usually incorporates activity monitoring, assessment of life goals and values, activity scheduling, skills training and problem solving, effective communication training, relaxation training, contingency management, and managing things like avoidance. Fellow occupational therapists will probably feel a tad superior here because these are core aspects of the ways in which occupational therapists work with people, but beware troops! The research from psychology is vast, and it’s rapidly gaining recognition as a psychological approach to reactivation. Beh...

Synergistic Anti-Tumor Effect of CRM197 & Paclitaxel in Ovarian Cancer

Libby's H*O*P*E* — Sun, 05 Apr 2009 23:31:22 +0100

CRM197, an inhibitor of heparin-binding EGF-like growth factor (HB-EGF), produces a synergistic ovarian cancer anti-tumor effect when combined with paclitaxel, according to study results published in the March 15th issue of the International Journal of Cancer. The investigators, Dr. Shingo Miyamoto and his colleagues, are affiliated with the Fukuoka University in Japan. “The treatment of [...] (Source: Libby's H*O*P*E*)